FTH
Faeth Therapeutics
$29.24
+$0.95 (+3.36%)Jul 27, 2026
Key metrics
The numbers that frame FTH today
- Market cap
- $39.24M
- P/E (TTM)
- -0.2
- EV / FCF
- 4.7
- ROIC
- -879.1%
- Div yield
- 0%
- 52wk Low
- $6.33
- 52wk High
- $37.90
Growth
Revenue and earnings trend for FTH
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about FTH
Is Faeth Therapeutics a good buy?
Hold. Faeth Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of FTH?
Faeth Therapeutics's market capitalization is $39.24M.
What is the P/E ratio for FTH stock?
Faeth Therapeutics's current P/E ratio is -0.2.
What is the 52-week high for FTH stock?
The 52-week high for Faeth Therapeutics is $37.90. The current close of $29.24 is 22.8% below that high.
What is the 52-week low for FTH stock?
The 52-week low for Faeth Therapeutics is $6.33. The current close of $29.24 is 362.3% above that low.
Does FTH stock pay dividends?
Faeth Therapeutics does not currently show a dividend per share in the company data.